BMY vs CPBI · P/E 17, rev $24.46B vs P/E 18, rev $27.7M
Bristol-Myers Squibb Company (BMY) versus Central Plains Bancshares, Inc. Common Stock (CPBI) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Central Plains Bancshares, Inc. Common Stock (CPBI) is a banks - regional company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported CPBI revenue for 2026-03-31 was $27.7M. Net income was $4.0M. Revenue was up 12.0% from 2025-03-31 to 2026-03-31. CPBI currently screens at market cap $77.8M and trailing P/E 18.0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. CPBI currently screens at market cap $77.8M and trailing P/E 18.0.
Not investment advice. Open the BMY and CPBI stock pages for the full models.
Not investment advice.